GZYK(002524)2025-01-24 10:05Financial Projections - The estimated operating revenue for 2024 is projected to be between 890 million and 960 million yuan, representing a decline of 10.69% to 17.20% compared to the previous year[4]. - The net profit attributable to shareholders is expected to be between -180 million and -120 million yuan, a decrease of 1,396.59% to 2,044.89% year-on-year[4]. - The net profit after deducting non-recurring gains and losses is projected to be between -190 million and -130 million yuan, reflecting a decline of 2,156.21% to 3,197.54% compared to the previous year[4]. - The basic earnings per share are expected to be between -0.35 yuan and -0.23 yuan, down from 0.02 yuan per share in the previous year[4]. Performance Challenges - The decline in performance is primarily attributed to intensified competition in the ophthalmology medical industry, leading to decreased revenue and gross profit from refractive and cataract projects[6]. - The medical segment's performance in 2024 is expected to fall short of expectations, potentially resulting in goodwill impairment and profit decline[6]. - The steel structure industry is also facing increased competition, resulting in a decrease in order volume and a subsequent decline in revenue and net profit compared to the previous year[6].